Enhancing communication about paediatric medicines: lessons from a qualitative study of parents' experiences of their child's suspected adverse drug reaction.

<h4>Background</h4>There is little research on parents' experiences of suspected adverse drug reactions in their children and hence little evidence to guide clinicians when communicating with families about problems associated with medicines.<h4>Objective</h4>To identify...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Janine Arnott, Hannah Hesselgreaves, Anthony J Nunn, Matthew Peak, Munir Pirmohamed, Rosalind L Smyth, Mark A Turner, Bridget Young
Formato:	article
Lenguaje:	EN
Publicado:	Public Library of Science (PLoS) 2012
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/327b212a7c934236b50ed8900ea3a4ff
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:327b212a7c934236b50ed8900ea3a4ff
record_format	dspace
spelling	oai:doaj.org-article:327b212a7c934236b50ed8900ea3a4ff2021-11-18T08:12:36ZEnhancing communication about paediatric medicines: lessons from a qualitative study of parents' experiences of their child's suspected adverse drug reaction.1932-620310.1371/journal.pone.0046022https://doaj.org/article/327b212a7c934236b50ed8900ea3a4ff2012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23071535/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>There is little research on parents' experiences of suspected adverse drug reactions in their children and hence little evidence to guide clinicians when communicating with families about problems associated with medicines.<h4>Objective</h4>To identify any unmet information and communication needs described by parents whose child had a suspected adverse drug reaction.<h4>Methods</h4>Semi-structured qualitative interviews with parents of 44 children who had a suspected adverse drug reaction identified on hospital admission, during in-patient treatment or reported by parents using the Yellow Card Scheme (the UK system for collecting spontaneous reports of adverse drug reactions). Interviews were conducted face-to-face or by telephone; most interviews were audiorecorded and transcribed. Analysis was informed by the principles of the constant comparative method.<h4>Results</h4>Many parents described being dissatisfied with how clinicians communicated about adverse drug reactions and unclear about the implications for their child's future use of medicines. A few parents felt that clinicians had abandoned their child and reported refusing the use of further medicines because they feared a repeated adverse drug reaction. The accounts of parents of children with cancer were different. They emphasised their confidence in clinicians' management of adverse drug reactions and described how clinicians prospectively explained the risks associated with medicines. Parents linked symptoms to medicines in ways that resembled the established reasoning that clinicians use to evaluate the possibility that a medicine has caused an adverse drug reaction.<h4>Conclusion</h4>Clinicians' communication about adverse drug reactions was poor from the perspective of parents, indicating that improvements are needed. The accounts of parents of children with cancer indicate that prospective explanation about adverse drug reactions at the time of prescription can be effective. Convergence between parents and clinicians in their reasoning for linking children's symptoms to medicines could be a starting point for improved communication.Janine ArnottHannah HesselgreavesAnthony J NunnMatthew PeakMunir PirmohamedRosalind L SmythMark A TurnerBridget YoungPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 10, p e46022 (2012)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Janine Arnott Hannah Hesselgreaves Anthony J Nunn Matthew Peak Munir Pirmohamed Rosalind L Smyth Mark A Turner Bridget Young Enhancing communication about paediatric medicines: lessons from a qualitative study of parents' experiences of their child's suspected adverse drug reaction.
description	<h4>Background</h4>There is little research on parents' experiences of suspected adverse drug reactions in their children and hence little evidence to guide clinicians when communicating with families about problems associated with medicines.<h4>Objective</h4>To identify any unmet information and communication needs described by parents whose child had a suspected adverse drug reaction.<h4>Methods</h4>Semi-structured qualitative interviews with parents of 44 children who had a suspected adverse drug reaction identified on hospital admission, during in-patient treatment or reported by parents using the Yellow Card Scheme (the UK system for collecting spontaneous reports of adverse drug reactions). Interviews were conducted face-to-face or by telephone; most interviews were audiorecorded and transcribed. Analysis was informed by the principles of the constant comparative method.<h4>Results</h4>Many parents described being dissatisfied with how clinicians communicated about adverse drug reactions and unclear about the implications for their child's future use of medicines. A few parents felt that clinicians had abandoned their child and reported refusing the use of further medicines because they feared a repeated adverse drug reaction. The accounts of parents of children with cancer were different. They emphasised their confidence in clinicians' management of adverse drug reactions and described how clinicians prospectively explained the risks associated with medicines. Parents linked symptoms to medicines in ways that resembled the established reasoning that clinicians use to evaluate the possibility that a medicine has caused an adverse drug reaction.<h4>Conclusion</h4>Clinicians' communication about adverse drug reactions was poor from the perspective of parents, indicating that improvements are needed. The accounts of parents of children with cancer indicate that prospective explanation about adverse drug reactions at the time of prescription can be effective. Convergence between parents and clinicians in their reasoning for linking children's symptoms to medicines could be a starting point for improved communication.
format	article
author	Janine Arnott Hannah Hesselgreaves Anthony J Nunn Matthew Peak Munir Pirmohamed Rosalind L Smyth Mark A Turner Bridget Young
author_facet	Janine Arnott Hannah Hesselgreaves Anthony J Nunn Matthew Peak Munir Pirmohamed Rosalind L Smyth Mark A Turner Bridget Young
author_sort	Janine Arnott
title	Enhancing communication about paediatric medicines: lessons from a qualitative study of parents' experiences of their child's suspected adverse drug reaction.
title_short	Enhancing communication about paediatric medicines: lessons from a qualitative study of parents' experiences of their child's suspected adverse drug reaction.
title_full	Enhancing communication about paediatric medicines: lessons from a qualitative study of parents' experiences of their child's suspected adverse drug reaction.
title_fullStr	Enhancing communication about paediatric medicines: lessons from a qualitative study of parents' experiences of their child's suspected adverse drug reaction.
title_full_unstemmed	Enhancing communication about paediatric medicines: lessons from a qualitative study of parents' experiences of their child's suspected adverse drug reaction.
title_sort	enhancing communication about paediatric medicines: lessons from a qualitative study of parents' experiences of their child's suspected adverse drug reaction.
publisher	Public Library of Science (PLoS)
publishDate	2012
url	https://doaj.org/article/327b212a7c934236b50ed8900ea3a4ff
work_keys_str_mv	AT janinearnott enhancingcommunicationaboutpaediatricmedicineslessonsfromaqualitativestudyofparentsexperiencesoftheirchildssuspectedadversedrugreaction AT hannahhesselgreaves enhancingcommunicationaboutpaediatricmedicineslessonsfromaqualitativestudyofparentsexperiencesoftheirchildssuspectedadversedrugreaction AT anthonyjnunn enhancingcommunicationaboutpaediatricmedicineslessonsfromaqualitativestudyofparentsexperiencesoftheirchildssuspectedadversedrugreaction AT matthewpeak enhancingcommunicationaboutpaediatricmedicineslessonsfromaqualitativestudyofparentsexperiencesoftheirchildssuspectedadversedrugreaction AT munirpirmohamed enhancingcommunicationaboutpaediatricmedicineslessonsfromaqualitativestudyofparentsexperiencesoftheirchildssuspectedadversedrugreaction AT rosalindlsmyth enhancingcommunicationaboutpaediatricmedicineslessonsfromaqualitativestudyofparentsexperiencesoftheirchildssuspectedadversedrugreaction AT markaturner enhancingcommunicationaboutpaediatricmedicineslessonsfromaqualitativestudyofparentsexperiencesoftheirchildssuspectedadversedrugreaction AT bridgetyoung enhancingcommunicationaboutpaediatricmedicineslessonsfromaqualitativestudyofparentsexperiencesoftheirchildssuspectedadversedrugreaction
_version_	1718422034555338752

Enhancing communication about paediatric medicines: lessons from a qualitative study of parents' experiences of their child's suspected adverse drug reaction.

Ejemplares similares